در این صفحه تعداد 48 مقاله تخصصی درباره که در نشریه های معتبر علمی و پایگاه ساینس دایرکت (Science Direct) منتشر شده، نمایش داده شده است. برخی از این مقالات، پیش تر به زبان فارسی ترجمه شده اند که با مراجعه به هر یک از آنها، می توانید متن کامل مقاله انگلیسی همراه با ترجمه فارسی آن را دریافت فرمایید. در صورتی که مقاله مورد نظر شما هنوز به فارسی ترجمه نشده باشد، مترجمان با تجربه ما آمادگی دارند آن را در اسرع وقت برای شما ترجمه نمایند.
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند. در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: cardio-oncology; cardiotoxicity; echocardiography; 2D; 2-dimensional; ASCO; American Society of Clinical Oncology; ASE; American Society of Echocardiography; CTRCD; cancer therapy-related cardiac dysfunction; EACVI; European Association of Cardiovascula
Keywords: AI; aromatase inhibitor; ASCO; American Society of Clinical Oncology; CDK4/6; cyclin-dependent kinase 4/6; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER; estrogen receptor; FDA; Food and Drug Administration; HER2; human epidermal growth f
Keywords: microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: ASCO; American Society of Clinical Oncology; ASE/EACVI; American Society of Echocardiography/European Association of Cardio-Vascular Imaging; ESMO; European Society of Medical Oncology; VSP; vascular endothelium growth factor pathway; TTE; transthoracic e
Keywords: Breast cancer; Imaging; Overuse; Utilization; Surveillance; Staging; ASCO; American Society of Clinical Oncology; NCCN; National Comprehensive Cancer Network; ESMO; European Society of Medical Oncology; ESO; European School for Oncology; MBC; metastatic b
Keywords: urogenital neoplasms; prostatic neoplasms; survivors; adverse effects; patient care planning; ACS; American College of Surgeons; ASCO; American Society of Clinical Oncologists; IOM; Institute of Medicine; PCP; primary care provider; SCP; survivorship care
Keywords: urology; venous thrombosis; pulmonary embolism; cost-benefit analysis; prevention & control; ACCP; American College of Chest Physicians; ASCO; American Society of Clinical Oncology; DVT; deep vein thrombosis; EDP; extended duration prophylaxis; ICER; incr
Keywords: Pathology report; Breast cancer; Registration; Quality; Variability; BCR; Belgian Cancer Registry; CAP; College of American Pathologists; IHC; immunohistochemistry; ISH; in situ hybridization; ASCO; American Society of Clinical Oncology; IDA; invasive duc
Keywords: Breast cancer; Lumpectomy; Surgical margin; Intraoperative evaluation; Imaging; Polarization; BCS; breast conserving surgery; RCM; reflectance confocal microscopy; OCM; optical coherence microscopy; ASCO; American Society of Clinical Oncologists; CAP; Col
Keywords: ACCP; American College of Chest Physicians; ASCO; American Society of Clinical Oncology; BMI; body mass index; CI; confidence intervals; DVT; deep vein thrombosis; ED; emergency department; FRSQ; Fonds de Recherche en Santé du Québec; GIS; Guaranteed In
Keywords: ASCO; American Society of Clinical Oncology; BRAF; B-raf proto-oncogene, serine/threonine kinase; CTLA4; cytotoxic T-lymphocyte associated protein 4; ESMO; European Society for Medical Oncology; FDA; Food and Drug Administration; ICER; incremental cost-ef
Keywords: anthracyclines; cancer treatment; cardiotoxicity; HER2-targeted therapy; LV dysfunction; ACCF; American College of Cardiology Foundation; AHA; American Heart Association; ASCO; American Society of Clinical Oncology; ASE; American Society of Echocardiograp
Keywords: urinary bladder neoplasms; radiotherapy; cystectomy; drug therapy; AC; adjuvant chemotherapy; AHRQ; Agency for Healthcare Research and Quality; ASCO; American Society of Clinical Oncology; ASTRO; American Society for Radiation Oncology; AUA; American Uro
Keywords: ABCC1/MRP; ATP binding cassette subfamily C member 1/ multidrug resistance protein; ABVD; doxorubicine-bleomycin-vinblastine-dacarbazine; AC; doxorubicin-cyclophosphamide; ANC; absolute neutrophil count; ASCO; American Society of Clinical Oncology; AUC; a
Keywords: ESMO; European Society for Medical Oncology; ASCO; American Society of Clinical Oncology; ECOG; Eastern Cooperative Oncology Group; Non small cell lung cancer; EGFR mutation; EGFR tyrosine kinase inhibitors; First line; Second line; Acquired resistance;
Keywords: ALN; axillary lymph node; ALND; axillary lymph node dissection; ASCO; American Society of Clinical Oncology; BMI; body mass index; FDA; Food and Drug Administration; FIRE; fluorescence image-guided resection equipment; HE; Hematoxylin-Eosin; ICG; indocyan
Keywords: AJCC; American Joint Committee on Cancer; ASCO; American Society of Clinical Oncology; CAP; College of American Pathologists; HR; hazard ratio; MSI; microsatellite instability; MSI-H; high level of microsatellite instability;
Keywords: adverse event; cancer; drug reaction; ipilimumab; melanoma; rash; AE; adverse events; ASCO; American Society of Clinical Oncology; CI; confidence interval; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; FDA; Food and Drug Administration; IL; inter
Keywords: Biomarker; Cancer; Tumor marker; ASCO; American Society of Clinical Oncology; EGFR; epidermal growth factor receptor; FISH; fluorescence in situ hybridization; IHC; immunohistochemistry; LOE; Level of Evidence; NCCN; National Comprehensive Cancer Network;
Keywords: Aromatase inhibitor; Bisphosphonate; Fracture risk; Osteopenia; Postmenopausal; Zoledronic acid; ABCSG; Austrian Breast and Colorectal Cancer Study Group; AI; aromatase inhibitor; AIBL; aromatase inhibitor bone loss; ASCO; American Society of Clinical Onc